Overall Status

Completed (3)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

University of California, Davis (1)

Collaborator

Novartis (1)

Intervention

bendamustine hydrochloride (1)

dasatinib (1)

everolimus (1)

laboratory biomarker analysis (1)

pharmacological study (1)

vorinostat (1)

Study Documents

Intervention Type

drug (3)

other (2)

Funder Type

NIH (2)

Other (1)

Study Type

Interventional (3)

recurrent mantle cell lymphoma

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in

Completed

Recurrent Adult Diffuse Large Cell Lymphoma
+7 more

everolimus
bendamustine hydrochloride

Sacramento, California

University of California Davis

Jan 2, 2019

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1

Completed

Has Results

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
+6 more

Laboratory Biomarker Analysis
Vorinostat

Duarte, California
+4 more

Feb 5, 2018

Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, Adult Hepatocellular Carcinoma Trial in

Completed

Adult Acute Lymphoblastic Leukemia in Remission
+84 more

Dasatinib
Pharmacological Study

Duarte, California
+22 more

Jun 30, 2015